InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,178.80
(
-0.10%
)
Dow Jones
39,806.77
(
0.00%
)
Brent Oil
82.04
(
-1.79%
)
Bitcoin
71,411.68
(
-0.05%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

nonewname1

Send PM Follow Ignore
Followers 36
Posts 2424
Boards Moderated 0
Alias Born 03/25/2009

nonewname1

Re: None

Monday, 03/20/2017 9:04:24 AM

Monday, March 20, 2017 9:04:24 AM

Post# of 21373
Here is a company that is somewhat similar to us in that it's on otc stock that has orphan designation and one drug in phase two clinical trials as well as others in the pipeline using the same type of treatment (this after 5 mins of DD so look into it yourself).

They also have some cash on hand as we expect to.

http://www.otcmarkets.com/stock/PMCB/profile

http://pharmacyte.com/research-development/


They have about 10 time the number of shares and are trading at .089 pps.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up